Stock information for PWRM, SOMX, and GENZ
Stock information for PWRM, SOMX, and GENZ
crwefinancelogo2
signup3m
Power3 Medical Products, Inc. (OTCBB:PWRM) reported that four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer’s Disease in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimer’s disease. The four studies to be presented involve a total of 154 Alzheimer’s disease patients and 91 Parkinson’s disease patients, as well as 210 age-matched normal control individuals and 173 disease control individuals.
PWRM is a leader in bio-medical research and the commercialization of biomarkers, tests, and mechanisms of disease. Power3′s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, and to identify protein biomarkers and drug targets, to fulfill critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).
Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX) a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, recently reported that detailed results from two Phase 3 clinical trials of the company’s product Silenor (doxepin) have been accepted for publication in peer-reviewed scientific journals.
During a twelve week evaluation period of the phase three clinical trial, 240 eldery subjects evaluated both objective polysomnography (PSG) and subjective measures of sleep. Another Phase 3 clinical trial enrolled 565 adults in a sleep laboratory setting using a phase-advance, first night assessment model of induced transient insomnia. The results of both tests demonstrated that Silenor achieved statistical significance for objective and subjective measures of sleep onset, including for the primary endpoint of Latency to Persistent Sleep (LPS), and sleep maintenance.
Genzyme Corporation (NASDAQ:GENZ) recently reported that it has entered into an agreement with Goldman, Sachs & Co. to repurchase billion of Genzyme common stock under an accelerated stock repurchase program. Proceeds from its recently concluded debt offering will be used to support this first tranche of Genzyme’s overall billion share repurchase plan that was announced in May.
Genzyme Corporation is one of the world’s leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 12,000 employees in locations spanning the globe and 2009 revenues of .5 billion. In 2010, Genzyme was named to the Fortune 500.
GENZ operates as a biotechnology company worldwide. It focuses on rare genetic disease disorders, renal diseases, orthopaedics, cancers, transplant and immune diseases, and diagnostic and predictive testing areas.
http://crwefinance.com/img/crwefinance_new_buscard2.jpg
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as ,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading shares for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB).
This shocking film examines the full ramifications of this explosive controversy and explores exactly what cloning is. See which animals have already been cloned and whether this technology can be refined to clone humans. The tangled ethical and technical issues surrounding cloning are fully explored by leading practitioners and thinkers in the field. Includes the facts about this controversial field of science along with a series of spellbinding interviews with researchers, scientists and legal experts including the most credible biotechnology authorities in the world today. NOW on DVD and loaded with Bonus Features and Interviews – Cat# k597 – Go to www.UFOTV.com.
Video Rating: 5 / 5
Categories: 2010 Discoveris Of Biotechnology Tags: "rule 17b", compensated, central nervous system, clinical validation, control individuals, drug response, drug targets, eldery, GENZ, Information, mechanisms of disease, medical products inc, otc:pwrm, peer reviewed scientific journals, pharmaceuticals inc, phase advance, power3 medical products, power3 medical products inc, protein biomarkers, PWRM, response test, somaxon pharmaceuticals, SOMX, Stock, subjective measures, transient insomnia
Lucintel Provides Aerospace and Automotive Market Research Reports at competitive price
Lucintel Provides Aerospace and Automotive Market Research Reports at competitive price
Lucintel, the US based company is the thoughtful and proficient provider of Aerospace, Automotive, Sporting, Marine Market Research Reports and every thing at viable prices. This company offers consulting services for making cutting decisions rapidly. It is hard to extort the Aerospace & Automotive Reports easily but Lucintel enables easy accessibility at low prices.
Undoubtedly the whole concept of business environment is an inevitable criterion for the set up, stabilization and survival in business. Be it any sort of dealing one has to be conscientious about the dynamic scenario of market, after every second there is a transformation in the graphs of marketplace yet it is an hard chore to track the rapid changes but being alert is incredibly fruitful. All I am stressing on the magnitude of Market Research Reports, which are prepared after wary surveys and analysis, these information’s creates the exact notion about where and how to move as per the market set-up. If you are in desperate hunt for Market Research Reports of areas like Aerospace, Automotive, or about any other activity then you can move towards Lucintel, the well known solution for buying market Research reports.
Lucintel, the veteran and proficient global management consulting and market researching firmenables the company to envisage their competitor activity, market trends, acceptability of their products, scope for new products and rationales of failures. Basically Lucintel offers Consulting services on the subject of capability, Capital investment, analysis, project feasibility assessment, due diligence and competitive benchmarking etc. And one can easily extort relevant market research reports concerning Aerospace, Automotive, Sporting and Marine at satisfying prices.
Aerospace Market Research Reports works as the tool for smooth and effective course of business, with the help of Lucintel one make critical decisions with great speed, insight and accuracy. We proffer Global Aerospace Market Trends of the financial years, Reports about opportunities for composites in Global Aerospace Market, and Opportunities in UAV Market 2008-2013: Materials, Markets and Technology Assessment at competitive rates. With precise analysis, one can makes profit easily and all it takes a low pocket expense.
While one can get Composites in the Passenger Rail Market, Market size, market share and Growth forecast of Global Passenger Rail Market, Materials and Application developments for the Passenger Rail Market, Opportunities for Composites in European Automotive Market Trends, Forecast, and Opportunity Analysis and mall recent updates about automotive market.
The grounds of success has roots of Lucintel’s equation, their services are effective and lucrative. If you are new then you can easily know the market by way of Lucintel. This US based company is offering services to Mercedes Benz, Sainta Gobain, Credit Suisse, Airbus, Barclays and all the successful companies existing in the market.
The author of this article is expert in writing articles about consulting. He has written articles about consulting and market research like aerospace consulting, wind consulting, and composite materials.
For more info visit: http://www.lucintel.com
Market Research Commandments 6 Let us backtrack to my latter point of finalizing commercial value when comparing keywords. In order to finalize commercial value let us look at our data through a different lense than our last example. Now let’s use this model for analyzing commercial value: 1) SEOV or SEO Value which is the sum of adding organic traffic or searches per day the top spot would expect to get from Google times the cost per click of that word in Adwords top positioning. We are assuming that the value is at least as high as the cost of the keyword otherwise competitors wouldn’t pay that price. 2) OCI or the pure Online Commercial Intention number as pulled from Bing. It is good to look at this number because it often reveals the percent of those keyword searchers who intend to buy. We cannot see that with CPC alone. 3) USP where traffic meets products and services. We must use our ideas to measure from a conceptual space if we can create a combination which is not already existing in the space of promotion to these keywords. This is the creative and ground breaking method by which whole new businesses are born. It can take your research to a new level, but for completely new ideas you should test the water before moving forward with your idea. You can run a survey from: related forums, social sites, and competitor sites. The other option is to buy traffic and survey it about your idea and to glean new ideas. 4) Competition must be considered for the keywords you …
Video Rating: 5 / 5
Categories: Buy Market Research Tags: acceptability, accessibility, Aerospace, aerospace market, alert, Automotive, automotive market, benchmarking, business environment, capability, capital, capital investment analysis, chore, competitive, competitor activity, Composites, cost, course, desperate hunt, due diligence, envisage, exact notion, feasibility assessment, Global, global management, Help, hunt, Information, Lucintel, management consulting, Market, market research reports, market trends, Markets, notion, number, pocket, price, project, project feasibility, Provides, rapid changes, rationales, relevant market, Reports, research, stabilization, survival in business, Tool, UAV, value, veteran
